biz@peptron.com
order@peptron.co.kr
ÆéÆ®·Ð¿¡¼ Á¦ÀÛÇÑ ÆéŸÀ̵带 »ç¿ëÇÏ¿© ¿¬±¸ ¹ßÇ¥µÈ ³í¹® ÀÚ·á ÀÔ´Ï´Ù.
ÀÛ¼ºÀÚ | °ü¸®ÀÚ | ÀϽà | 2020-07-10 17:08:55 |
---|---|---|---|
±ÛÁ¦¸ñ | N-terminal modification of the tetrapeptide Arg-Leu-Tyr-Glu, a vascular endothelial growth factor receptor-2 (VEGFR-2) antagonist, improves antitumor activity by increasing its stability against serum |
![]() |
Total : 246 Page : ( 25/1 )
|
![]() |